In support of our findings, a recent paper by Jang et al. showed that the L1PA2-derived promoter activity was not limited to SYT1, and was also seen for other oncogenes, such as MET, XCL1 and AKAP13, in a number of cancer types22–25,36. The gene discussed is MET; the disease is cancer.